Biliary Lithotripter Market Size, Share Global Analysis Report, 2024 – 2032

Industry Insights

[204+ Pages Report] According to Facts & Factors, the global biliary lithotripter market size in terms of revenue was valued at around USD 1,770 million in 2023 and is expected to reach a value of USD 2,630 million by 2032, growing at a CAGR of roughly 4.5% from 2024 to 2032. The global biliary lithotripter market is projected to grow at a significant growth rate due to several driving factors.

Market Overview

A biliary lithotripter is a medical device used to fragment gallstones in the bile channels. The ducts carry bile, a digesting fluid, from the liver and gallbladder to the small intestine. Gallstones, made of cholesterol and other substances, can obstruct these ducts, leading to discomfort and other issues.

Lithotripsy provides a non-traditional method for removing gallstones compared to surgery. It can be executed using various methods, such as Mechanical lithotripsy involves using a specific device to grab and crush the gallstone. Electrohydraulic lithotripsy uses high-frequency electrical energy to generate shockwaves that break down the stone. Laser lithotripsy uses laser energy to disintegrate the stone.

Key Highlights

• The biliary lithotripter market has registered a CAGR of 4.5% during the forecast period.
• In terms of revenue, the global biliary lithotripter market was estimated at roughly USD 1,770 million in 2023 and is predicted to attain a value of USD 2,630 million by 2032.
• The growth of the biliary lithotripter market is being propelled by the increased incidence of gallstones, the increasing elderly population, and the expanding use of minimally invasive techniques.
• On the basis of Technology, the electromagnetic lithotripsy (ESWL) segment is currently the dominant segment due to its established use and non-invasive nature.
• Based on End-User, the hospitals segment holds the dominant share due to the availability of advanced equipment
• By region, North America is the leading market with a high Compound Annual Growth Rate (CAGR) of 5.7% in the coming years.

Key Growth Drivers:

• Rising prevalence of gallstones: The increasing incidence of gallstones, driven by factors like unhealthy diet, obesity, and the aging population, is a major driver for the biliary lithotripter market.
• Technological advancements: Advancements in lithotripsy technologies, such as the miniaturization of devices and improved targeting accuracy, are making the procedure less invasive and more efficient, leading to increased adoption.
• Growing geriatric population: The growing geriatric population, who are more susceptible to gallstone formation, is expected to fuel market demand for biliary lithotripters.

Restraints:

• High treatment cost: The high cost associated with biliary lithotripsy, including equipment, procedure fees, and potential hospitalization, can deter patients and limit market growth, especially in regions with limited healthcare access.
• Side effects and limitations: While non-invasive, biliary lithotripsy can have side effects like pain, nausea, and bleeding, and may not be effective for all types of gallstones, particularly large or hard ones.
• Stringent regulatory environment: Strict regulatory requirements for device approval and reimbursement can hinder market entry for new players and slow down the adoption of innovative technologies.

Opportunities:

• Emerging markets: Developing regions with rising disposable income and increasing healthcare infrastructure are presenting lucrative opportunities for market expansion.
• Technological innovation: Continuous advancements in lithotripsy technology, such as the development of laser lithotripsy and robotic-assisted procedures, have the potential to further improve treatment efficacy and accessibility, driving market growth.
• Growing awareness: Increased public awareness about minimally invasive procedures for gallstone removal can encourage patients to seek treatment with biliary lithotripters.

Challenges:

• Stringent regulatory environment: Strict regulatory requirements and approval processes for medical devices can delay market entry for new technologies and hinder innovation.
• Competition from alternative treatment options: The presence of established and less expensive treatment options, such as laparoscopic cholecystectomy (gallbladder removal surgery), may pose a challenge for the biliary lithotripter market.
• Reimbursement concerns: Uncertainties surrounding reimbursement policies for biliary lithotripsy procedures by insurance companies can create limitations for both patients and healthcare providers.

Biliary Lithotripter Market: Segmentation Analysis

The global Biliary Lithotripter market is segmented based on technology, application, end-user, and region. Here's an analysis of key segments with their dominating sub-segments:

Based on Technology, the global biliary lithotripter market is bifurcated into electrohydraulic lithotripsy, laser lithotripsy, and ultrasonic lithotripsy. The Electrohydraulic lithotripsy technology uses shockwaves generated by electricity to fragment gallstones. It currently holds the largest market share (CAGR: 3.4%) due to its established presence and effectiveness.

The laser lithotripsy segment utilizes laser energy to break down stones, offering greater precision but limited availability. It's expected to experience the highest CAGR of 5.6% due to its growing adoption and potential for minimally invasive procedures. Employing sound waves for stone fragmentation, the Ultrasonic lithotripsy segment has a smaller market share but holds promise for specific stone types. Its growth is projected to be moderate.

By Application, the global biliary lithotripter market is categorized into choledocholithiasis and cholecystolithiasis. Choledocholithiasis (stones in the bile duct) is the dominant application, accounting for a significant portion of the market due to the prevalence of this condition growing at a CAGR of 4.5% over the forecast period.

While a prevalent condition, the Cholecystolithiasis (stones in the gallbladder) segment faces competition from alternative therapies like laparoscopic cholecystectomy, limiting its growth to a moderate CAGR of 2.3%.

Based on End-Users, the global biliary lithotripter market is categorized into hospitals and ambulatory surgical centers (ASCs). Hospitals are the leading segment with a CAGR of 3.4% due to the presence of specialized equipment and expertise for lithotripsy procedures. While as ambulatory surgical centers (ASCs) driving the fastest growth in this segment due to the growing trend of minimally invasive procedures.

Recent Developments

• March 2021: Boston Scientific acquired Lumenis for $1.1 billion. This move strengthened Boston Scientific's lithotripsy device portfolio, which includes biliary lithotripters used to treat gallstones.

Report Scope

Biliary Lithotripter Market: Regional Analysis

• North America: Currently holds the dominant position in the market with a high CAGR of 5.7% over the next few years due to factors like advanced healthcare infrastructure, favorable reimbursement policies, and high disposable income.
• Europe: The second-largest market, driven by similar factors as North America, but with slightly lower CAGR due to stricter regulatory frameworks.
• Asia Pacific: This region is expected to witness the fastest growth due to a large and growing patient pool, increasing disposable income, and rising awareness of minimally invasive procedures.
• Rest of the World (ROW): This region, including Latin America, the Middle East, and Africa, is expected to show moderate growth due to developing healthcare infrastructure and increasing investments in the medical device sector.

Biliary Lithotripter Market: Competitive Landscape

Some of the main competitors dominating the global Biliary Lithotripter market include;

• Olympus Corporation (Japan)
• Cook Medical (US)
• Boston Scientific (US)
• Guangzhou Pudong Kangda Medical Equipment Co., Ltd. (China)
• EDAP TMS (France)
• Direx Technologies (Germany)
• Becton, Dickinson and Company (US)
• Siemens Healthineers (Germany)
• Dornier MedTech (Germany)

The global Biliary Lithotripter market is segmented as follows:

By Technology Segment Analysis

• Electrohydraulic Lithotripsy
• Laser Lithotripsy
• Ultrasonic Lithotripsy

By Application Segment Analysis

• Choledocholithiasis
• Cholecystolithiasis

By End-Users Segment Analysis

• Hospitals
• Ambulatory Surgical Centers [ASCs]

By Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America